New Prostate Cancer Drug Shrinks Tumors in Half of Patients

A groundbreaking immunotherapy drug halted or shrank tumors in nearly half of men with advanced prostate cancer who had run out of treatment options.

The therapy works differently than previous treatments and caused only mild side effects in 88% of patients.